Volume 20 Issue 12
Dec.  2022
Turn off MathJax
Article Contents
CHEN Dong, FENG Jun, SU Hao, ZHANG Jing. Clinical value of plasma adiponectin in the diagnosis of chronic heart failure[J]. Chinese Journal of General Practice, 2022, 20(12): 2059-2062. doi: 10.16766/j.cnki.issn.1674-4152.002769
Citation: CHEN Dong, FENG Jun, SU Hao, ZHANG Jing. Clinical value of plasma adiponectin in the diagnosis of chronic heart failure[J]. Chinese Journal of General Practice, 2022, 20(12): 2059-2062. doi: 10.16766/j.cnki.issn.1674-4152.002769

Clinical value of plasma adiponectin in the diagnosis of chronic heart failure

doi: 10.16766/j.cnki.issn.1674-4152.002769
Funds:

 202104j07020058

 2020xkj073

 2020byzd297

  • Received Date: 2022-03-30
    Available Online: 2023-02-07
  •   Objective  To investigate the clinical value of plasma adiponectin (APN) in the diagnosis of chronic heart failure (CHF).  Methods  A total of 48 patients with CHF diagnosed in Anhui Provincial Hospital from May 2018 to May 2019 were included as CHF group, and 40 healthy volunteers were included as control group. The levels of plasma APN and NT-proBNP in the two groups were compared, the left ventricular ejection fraction (LVEF) in CHF group was obtained, and the correlation between plasma APN, NT-proBNP and LVEF in CHF group was analyzed. CHF patients were divided into groups by cardiac function classification of New York Heart Association (NYHA), and plasma APN, NT-proBNP and LVEF were compared between subgroups. Plasma APN, NT-proBNP and LVEF were collected before and 3 and 6 months after treatment in CHF group, and the diagnostic value of APN in CHF was preliminarily analyzed.  Results  In the CHF group, the age was 45-91 (60.98±13.98) years, with 34 males and 14 females. In the control group, the age was 51-93 (57.88±13.76) years, with 28 males and 12 females. The plasma APN and NT-proBNP in the CHF group were (23.08±9.39) μg/mL, 5 455.00 (1 256.00, 8 552.25) pg/mL, respectively, which were higher than those in the control group [(12.06±3.28) μg/mL and 55.50 (32.00, 78.50) pg/mL], the differences were statistically significant (all P < 0.05). Pearson linear relationship analysis showed that the plasma APN was positively correlated with NT-pro BNP and negatively correlated with LVEF in the CHF group. The APN and NT-proBNP increased significantly with the increase of cardiac function grade, but LVEF decreased significantly. During the follow-up, the plasma APN and NT-proBNP decreased significantly with the improvement of the disease, but LVEF increased significantly.  Conclusion  The plasma APN is positively correlated with NT-proBNP and negatively correlated with LVEF in patients with CHF, which is consistent with NYHA cardiac function grade. It has certain predictive value for clinical diagnosis of CHF.

     

  • loading
  • [1]
    陈东, 苏浩, 徐健, 等. 左室心内膜起搏实现心脏再同步化治疗的临床研究[J]. 中华全科医学, 2019, 17(9): 1485-1490. doi: 10.16766/j.cnki.issn.1674-4152.000976

    CHEN D, SU H, XU J, et al. Clinical study of left ventricular endocardial pacing in cardiac resynchronization therapy[J]. Chinese Journal of General Practice, 2019, 17(9): 1485-1490. doi: 10.16766/j.cnki.issn.1674-4152.000976
    [2]
    GE Z, BABER U, CLAESSEN B E, et al. The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry[J]. Catheter Cardiovasc Interv, 2019, 93(3): E112-E119. doi: 10.1002/ccd.27860
    [3]
    HUUSKO J, KURKI S, TOPPILA I, et al. Heart failure in Finland: Clinical characteristics, mortality, and healthcare resource use[J]. ESC Heart Fail, 2019, 6(4): 603-612. doi: 10.1002/ehf2.12443
    [4]
    GALLAGHER J, MCCORMACK D, ZHOU S W, et al. A systematic review of clinical prediction rules for the diagnosis of chronic heart failure[J]. ESC Heart Fail, 2019, 6(3): 499-508. doi: 10.1002/ehf2.12426
    [5]
    MANTOVANI A, DANESE E, SALVAGNO G L, et al. Association between lower plasma adiponectin levels and higher plasma thrombin generation parameters in men with type 2 diabetes: Role of plasma triglycerides[J]. J Endocrinol Invest, 2021, 44(3): 547-555. doi: 10.1007/s40618-020-01340-3
    [6]
    PUCHAŁOWICZ K, KŁODA K, DZIEDZIEJKO, et al. Association of adiponectin, leptin and resistin plasma concentrations with echocardiographic parameters in patients with coronary artery disease[J]. Diagnostics(Basel), 2021, 11(10): 1774.
    [7]
    TANAKA Y, KITA S, NISHIZAWA H, et al. Adiponectin promotes muscle regeneration through binding to T-cadherin[J]. Sci Rep, 2019, 9(1): 16. doi: 10.1038/s41598-018-37115-3
    [8]
    BAYES-GENIS A, CEDIEL G, DOMINGO M, et al. Biomarkers in heart failure with preserved ejection fraction[J]. Card Fail Rev, 2022, 8: e20. doi: 10.15420/cfr.2021.37
    [9]
    OH A, OKAZAKI R, SAM F, et al. Heart failure with preserved ejection fraction and adipose tissue: A story of two tales[J]. Front Cardiovasc Med, 2019, 6: 110-119. doi: 10.3389/fcvm.2019.00110
    [10]
    GRUZDEVA O V, DYLEVA Y A, BELIK E V, et al. Relationship between epicardial and coronary adipose tissue and the expression of adiponectin, leptin, and interleukin 6 in patients with coronary artery disease[J]. J Pers Med, 2022, 12(2): 129-145. doi: 10.3390/jpm12020129
    [11]
    LUO D L, CHEN P Y, YANG Z Y, et al. High plasma adiponectin is associated with increased pulmonary blood flow and reduced right ventricular function in patients with pulmonary hypertension[J]. BMC Pulm Med, 2020, 20(1): 204-212. doi: 10.1186/s12890-020-01233-4
    [12]
    EMDIN M, AIMO A, VERGARO G, et al. sST2 predicts outcome in chronic heart failure beyond NT-proBNP and high-sensitivity troponin T[J]. J Am Coll Cardiol, 2018, 72(19): 2309-2320. doi: 10.1016/j.jacc.2018.08.2165
    [13]
    JANUZZI J L, AHMAD T, MULDER H, et al. Natriuretic peptide response and outcomes in chronic heart failure with reduced ejection fraction[J]. J Am Coll Cardiol, 2019, 74(9): 1205-1217. doi: 10.1016/j.jacc.2019.06.055
    [14]
    PAN Y S, LI D J, MA J, et al. NT-proBNP test with improved accuracy for the diagnosis of chronic heart failure[J]. Medicine, 2017, 96(51): e9181-e9187. doi: 10.1097/MD.0000000000009181
    [15]
    STIENEN S, SALAH K, MOONS A H, et al. NT-proBNP (N-terminal pro-B-type natriuretic peptide)-guided therapy in acute decompensated heart failure: PRIMA Ⅱ randomized controlled trial (can NT-ProBNP-guided therapy during hospital admission for acute decompensated heart failure reduce mortality and readmissions?)[J]. Circulation, 2018, 137(16): 1671-1683. doi: 10.1161/CIRCULATIONAHA.117.029882
    [16]
    HORBAL S R, HALL M E, DINH P C, et al. Associations of adiponectin and leptin with brain natriuretic peptide in African Americans: The Jackson heart study[J]. Cardiovasc Endocrinol Metab, 2020, 9(2): 49-55. doi: 10.1097/XCE.0000000000000198
    [17]
    WANG H, GAO Y X, WU Y N, et al. Association between plasma adiponectin levels and left ventricular systolic dysfunction in sepsis patients[J]. J Crit Care, 2020, 60: 195-201. doi: 10.1016/j.jcrc.2020.06.020
    [18]
    VAN BERENDONCKS A M, BECKERS P, HOYMANS V Y, et al. β-blockers modify the prognostic value of adiponectin in chronic heart failure[J]. Int J Cardio, 2011, 150(3): 296-300. doi: 10.1016/j.ijcard.2010.04.039
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(3)

    Article Metrics

    Article views (204) PDF downloads(4) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return